Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Predictors of progression in albuminuria in the general population: results from the PREVEND cohort.

Scheven L, Halbesma N, de Jong PE, de Zeeuw D, Bakker SJ, Gansevoort RT.

PLoS One. 2013 May 27;8(5):e61119. doi: 10.1371/journal.pone.0061119. Print 2013.

2.

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.

Atthobari J, Brantsma AH, Gansevoort RT, Visser ST, Asselbergs FW, van Gilst WH, de Jong PE, de Jong-van den Berg LT; PREVEND study group.

Nephrol Dial Transplant. 2006 Nov;21(11):3106-14. Epub 2006 May 23.

PMID:
16720593
3.

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.

Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ; Prevention of Renal and Vascular End Stage Disease Study Group.

Clin Ther. 2010 Jun;32(6):1103-21. doi: 10.1016/j.clinthera.2010.06.013.

PMID:
20637965
4.

Development and validation of a general population renal risk score.

Halbesma N, Jansen DF, Heymans MW, Stolk RP, de Jong PE, Gansevoort RT; PREVEND Study Group.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8. doi: 10.2215/CJN.08590910.

5.

Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes.

Yokoyama H, Kanno S, Takahashi S, Yamada D, Honjo J, Saito K, Sone H, Haneda M.

Nephrol Dial Transplant. 2011 Sep;26(9):2924-30. doi: 10.1093/ndt/gfq774. Epub 2011 Feb 8.

PMID:
21303964
6.

Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study.

Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I.

Atherosclerosis. 2008 Dec;201(2):398-406. doi: 10.1016/j.atherosclerosis.2008.02.027. Epub 2008 Mar 6.

PMID:
18405901
7.

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.

Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356. Epub 2008 Jul 18.

PMID:
18641082
8.

What predicts progression and regression of urinary albumin excretion in the nondiabetic population?

Brantsma AH, Atthobari J, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT.

J Am Soc Nephrol. 2007 Feb;18(2):637-45. Epub 2007 Jan 10.

9.

Glomerular and tubular damage markers in individuals with progressive albuminuria.

Nauta FL, Scheven L, Meijer E, van Oeveren W, de Jong PE, Bakker SJ, Gansevoort RT.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1106-14. doi: 10.2215/CJN.04510512. Epub 2013 Mar 28.

10.

Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study.

Halbesma N, Jansen DF, Stolk RP, De Jong PE, Gansevoort RT; PREVEND Study group.

Nephrol Dial Transplant. 2010 Jun;25(6):1846-53. doi: 10.1093/ndt/gfp729. Epub 2010 Jan 6.

PMID:
20054026
11.

Impact of weight change on albuminuria in the general population.

Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, Gansevoort RT.

Nephrol Dial Transplant. 2007 Jun;22(6):1619-27. Epub 2007 Mar 14.

PMID:
17360767
12.

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.

Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group.

Kidney Int Suppl. 2004 Nov;(92):S18-21. Review.

PMID:
15485409
13.

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.

Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT.

J Am Soc Nephrol. 2006 Sep;17(9):2582-90. Epub 2006 Aug 9.

14.

Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.

Andrésdóttir G, Bakker SJ, Hansen HP, Parving HH, Rossing P.

Diabet Med. 2013 May;30(5):563-6. doi: 10.1111/dme.12131. Epub 2013 Mar 7.

PMID:
23324103
15.

Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.

Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease).

Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005.

PMID:
21357908
16.

Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study.

Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE.

Am J Kidney Dis. 2014 Mar;63(3):415-21. doi: 10.1053/j.ajkd.2013.10.061. Epub 2013 Dec 21.

17.
18.

Screening for albuminuria identifies individuals at increased renal risk.

van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT.

J Am Soc Nephrol. 2009 Apr;20(4):852-62. doi: 10.1681/ASN.2008060655. Epub 2009 Feb 11.

19.

Factors associated with impaired urinary albumin excretion in hypertensive individuals: albuminuria and hypertension.

de Melo RO, Toledo JC, Souza DR, Martin JF.

Int J Cardiol. 2010 Nov 19;145(2):329-31. doi: 10.1016/j.ijcard.2009.11.052. Epub 2009 Dec 16.

PMID:
20018394
20.

Supplemental Content

Support Center